Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05965622
Other study ID # NL82274.018.22
Secondary ID S65701
Status Recruiting
Phase N/A
First received
Last updated
Start date August 1, 2023
Est. completion date November 14, 2026

Study information

Verified date July 2023
Source Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Contact Claudi L.H. Bockting, Professor
Phone +3120-8913600
Email c.l.bockting@amsterdamumc.nl
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Young adults who attempt to kill themselves is a common and serious mental health problem worldwide and certainly in Belgium and the Netherlands. Fatal suicide is the leading cause of death among young adults. It has devastating consequences both for the young adults themselves and for their families. It also has substantial economic costs. However, up until now, there is little research on the treatment of suicidality among young adults. The current psychological therapy approaches and drug treatments for young people at very high risk of fatal suicide attempts have only limited success. Increasing evidence indicates the importance of involving significant others in treatment and the importance of the unfulfilled need for belonging and secure attachment. The WHO recommends involving significant others in the treatment of suicidal young adults. However, in Belgium and the Netherlands, there is little knowledge on the effectiveness of family based treatments. Attachment Based Family Therapy, or ABFT, was shown to work well in several studies in the US. Also in Belgium and the Netherlands, ABFT is being used to treat suicidal young adults. However, how well it works compared to the current treatment and if it provides good value for money have not been studied in young adults. In the proposed study the investigators will test, in a real-life situation, whether ABFT works better than the current treatment and if it provides good value for money. This study is a collaboration between the Netherlands and Belgium and 6 or 7 sites will participate from each country. Sites can be hospitals, mental health centres, student health centres or private practices. Participants (138 individuals) are young adults between 18 and 25 years old who have frequent thoughts about killing themselves, and who seek mental health treatment. The investigators predict that, compared to current treatment, ABFT will reduce suicidal thoughts and suicide attempts and that this improvement will be maintained over time, and that it will be better value for money. The project will contribute to improving care for suicidal young adults with high suicide risk. Results will inform clinical guidelines and policymakers and improve the treatment of young adults with a high risk for fatal suicide, and their families.


Description:

The investigators conduct a randomized controlled trial to evaluate the (cost-)effectiveness of ABFT compared to Treatment As Usual (TAU) on suicidality, as delivered in daily practice. The hypothesis is that, compared to TAU, ABFT will lead to a stronger reduction of suicidal ideation and suicidal behavior, and will be more cost-effective, will improve family functioning and young adult attachment, and that this effect will hold at follow-up. The primary objective is change in suicidality, that is, suicidal ideation, attempts and suicide as assessed by the Suicidal Ideation Questionnaire Junior (SIQ-JR), and as reported by therapists during treatment. Secondary objectives are cost-effectiveness, process, working alliance and adherence during treatment, and change in young adult depressive symptoms, family functioning, and young adult attachment. Attachment Based Family Therapy (ABFT): ABFT is a manualized treatment, that emerges from interpersonal theories that suggest suicide can be precipitated, exacerbated, or buffered against by the quality of family relationships. Therefore, ABFT focuses on strengthening parent-child attachment bonds to create a protective and secure base for young adult development. Sessions are scheduled weekly, and the intervention lasts on average 16 weeks. Treatment as usual (TAU): Participants in both arms will receive TAU, in the experimental condition ABFT will be delivered as an add-on. Most treatment centres' clinical practices rely heavily on the use of antidepressants and/or CBT or DBT. All regular interventions are allowed in TAU, except for systemic family therapy of more than 4 sessions in total. Parents are allowed to be involved in the treatment, which is part of treatment as usual, and can comprise for instance psycho-education or parental support or skill training.


Recruitment information / eligibility

Status Recruiting
Enrollment 138
Est. completion date November 14, 2026
Est. primary completion date November 15, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years to 25 Years
Eligibility Inclusion Criteria: - Aged between 18 and 25. - A score above 31 on the SIQ-JR (the cut-off for suicidality). - Have at least one primary parent or caregiver that participates in the assessment and treatment. This could be a biological parent, stepparent, grandparent, other relative, or a foster parent. Exclusion Criteria: - Other DSM-5 disorders: modest/severe substance dependency, severe conduct disorder, evidence of psychotic features or prior psychosis (assessed with the SCID-5-S). - Severe cognitive impairment (e.g., mental retardation, severe developmental disorders) as evidenced by educational records, parental report and/or clinical impression. - Other circumstances that might affect participation (e.g., severe medical disorder, relocation).

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Attachment Based Family Therapy (ABFT) + Treatment As Usual (TAU)
Attachment Based Family Therapy (ABFT): ABFT is a manualized treatment, that emerges from interpersonal theories that suggest suicide can be precipitated, exacerbated, or buffered against by the quality of family relationships. Therefore, ABFT focuses on strengthening parent-child attachment bonds to create a protective and secure base for young adult development. Sessions are scheduled weekly, and the intervention lasts on average 16 weeks. The participants in the ABFT condition will also receive treatment as usual (TAU).
Treatment As Usual (TAU)
The participants in the treatment as usual (TAU) condition will only receive regular existing care to treat suicidality in young adults.

Locations

Country Name City State
Netherlands GGZ OostBrabant Oss Noord Holland

Sponsors (4)

Lead Sponsor Collaborator
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Belgium Health Care Knowledge Centre, KU Leuven, ZonMw: The Netherlands Organisation for Health Research and Development

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Other Childhood Trauma Childhood Trauma Questionnaire (CTQ). This is a self-report 28-item questionnaire that measures 5 types of maltreatment: emotional, physical, and sexual abuse, and emotional and physical neglect. Baseline
Other Working Alliance Inventory Working Alliance Inventory (WAI). Measures overall therapeutic alliance and consists of sub scales measuring (quality of therapy) tasks, goals and bonds. Admistered to young adult and the participating parent or caregiver. Every 2 months during intervention starting at the first session
Other Treatment fidelity The Therapist Behavior Rating Scale-3 & non-verbal contact will be assessd via videotaping by a trained researcher. Every 2 months during intervention starting at the first session
Other Therapy Procedure Therapy Procedures Checklist (TPC). It assesses therapists' reports of the techniques they employ when working with child and adolescent clients, and will be used to monitor Treatment as Usual in both study arms. TPC items encompass the 3 most common therapeutic models for youth: psychodynamic, cognitive, and behavioural. Every 2 months during intervention starting at the first session
Other Demographic characteristics and other parameters Demographic characteristics: age, marital status, gender, ethnicity, level of education, medication use, substance use (smoking, alcohol, drugs), psychiatric history (therapy, medication, number of previous episodes, duration of episodes and treatment). Baseline
Primary Suicidality Suicidality is assessed by the SIQ-JR. (Reynolds & Mazza, 1999) Measures change at: baseline, 5 months after baseline (immediately after intervention).Follow-up: 3-mo after intervention (i.e. 8 mo after baseline), 6 mo after intervention (i.e11-mo after baseline) 12 mo after intervention(i.e.17 mo after baseline)
Secondary Suicide ideation Assessed with the SCID-5-S, DSM 5 diagnostic interview. Michael B.First, JBWW, Lorna Smith Benjamin, Robert L. Spitzer, 2017) Measures change at: baseline, 5 months after baseline (after intervention).Follow-up: 3-months after intervention (i.e. 8 months after baseline), 12-months after intervention (i.e. 17 months after baseline)
Secondary Suicide attempts Assessed with the SCID-5-S, DSM 5 diagnostic interview. Michael B.First, JBWW, Lorna Smith Benjamin, Robert L. Spitzer, 2017) Measures change at: baseline, 5 months after baseline (after intervention).Follow-up: 3-months after intervention (i.e. 8 months after baseline), 12-months after intervention (i.e. 17 months after baseline)
Secondary Depression (DSM 5) Assessed with the SCID-5-S, DSM 5 diagnostic interview. Michael B.First, JBWW, Lorna Smith Benjamin, Robert L. Spitzer, 2017) Measures change at: baseline, 5 months after baseline (after intervention).Follow-up: 3-months after intervention (i.e. 8 months after baseline), 12-months after intervention (i.e. 17 months after baseline)
Secondary Depressive symptoms Patient Health Questionnaire (PHQ-9).(Kroenke, Spitzer & Williams, 2001) Measures change at: baseline, 5 months after baseline (immediately after intervention).Follow-up: 3-mo after intervention (i.e. 8 mo after baseline), 6 mo after intervention (i.e11-mo after baseline) 12 mo after intervention(i.e.17 mo after baseline)
Secondary Parental vision on the young adults depressive symptoms Parental vision on the young adults depression symptoms Clinical Depression Inventory second edition (CDI-2) (Bodden, Braet,
& Stikkelbroek, 2016.) .
Measures change at: baseline, 5 months after baseline (immediately after intervention).Follow-up: 3-mo after intervention (i.e. 8 mo after baseline), 6 mo after intervention (i.e11-mo after baseline) 12 mo after intervention(i.e.17 mo after baseline)
Secondary Family functioning Self Report Measures of Family Functioning (SRFF). (Stark et al., 1990), both the young adult and the parents/caregiver Measures change at: baseline, 5 months after baseline (immediately after intervention).Follow-up: 3-mo after intervention (i.e. 8 mo after baseline), 6 mo after intervention (i.e11-mo after baseline) 12 mo after intervention(i.e.17 mo after baseline)
Secondary Attachment Secure Base Script (SBS) task to asses attachment. (Waters et al., 2019; Waters & Roisman, 2019) Measures change at: baseline, 5 months after baseline (immediately after intervention).Follow-up: 3-months after intervention (i.e. 8 months after baseline), 12-months after intervention (i.e. 17 months after baseline)
Secondary Health-related quality of life Health-related quality of life: EQ-5D-5L (Versteegh et al., 2016) Measures change at: baseline, 5 months after baseline (immediately after intervention).Follow-up: 3-months after intervention (i.e. 8 months after baseline), 12-months after intervention (i.e. 17 months after baseline)
Secondary Disability World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0). (Ustun, Kostanjsek, Chatterji & Rehm, 2010) Measures change at: baseline, 5 months after baseline (immediately after intervention).Follow-up: 3-months after intervention (i.e. 8 months after baseline), 12-months after intervention (i.e. 17 months after baseline)
Secondary Non-suicidal self-injury Non-suicidal self-injury questionnaire.(Buelens, T., Luyckx, K., Kiekens, G., Gandhi, A., Muehlenkamp, J. J., & Claes, L. (2020). Measures change at: baseline, 5 months after baseline (immediately after intervention).Follow-up: 3-mo after intervention (i.e. 8 mo after baseline), 6 mo after intervention (i.e11-mo after baseline) 12 mo after intervention(i.e.17 mo after baseline)
Secondary Autonomy Autonomy of the young adult, as assessed by the questionnaire. My Parents and I, a combination of items of the Emotional Autonomy Scale (EAS; Steinberg & Zilverberg, 1986) and the Psychological Separation Inventory (PSI; Hoffman 1984). Measures change at: baseline, 5 months after baseline (immediately after intervention).Follow-up: 3-mo after intervention (i.e. 8 mo after baseline), 6 mo after intervention (i.e11-mo after baseline) 12 mo after intervention(i.e.17 mo after baseline)
Secondary Entrapment Entrapment Short-Form Scale (E-SF; De Beurs et al., 2020). The E-SF is a 4-item questionnaire. Measures change at: baseline, 5 months after baseline (immediately after intervention).Follow-up: 3-mo after intervention (i.e. 8 mo after baseline), 6 mo after intervention (i.e11-mo after baseline) 12 mo after intervention(i.e.17 mo after baseline)
Secondary Health care and associated costs and costs from productivity loss Health care and associated costs and costs from productivity loss: TiC-P (Hakkaart-Van Roijen, 2002). Measures change at: baseline, 5 months after baseline (immediately after intervention).Follow-up: 3-months after intervention (i.e. 8 months after baseline), 12-months after intervention (i.e. 17 months after baseline)
See also
  Status Clinical Trial Phase
Recruiting NCT05334381 - Navigating Mental Health Treatment for Black Youth N/A
Recruiting NCT04653337 - Neuroimaging Guided and Robot-assisted rTMS for Suicidal Ideation of Depression Phase 2
Terminated NCT04254809 - Evaluation of a Computerized Intervention for Learning to Re-Evaluate Suicidal Thoughts N/A
Recruiting NCT05848089 - Real-time Intervention for Suicide Risk Reduction N/A
Recruiting NCT06322199 - Differences Between Suicide Attempters and Suicide Ideators. Influence of the Brief Therapy Attempted Suicide Short Intervention Program (ASSIP) on Neuropsychological Correlates and Psychological Process Factors - Project 3
Completed NCT05280756 - Home-based tDCS for Prevention of Suicidal Ideation N/A
Not yet recruiting NCT06454136 - Pilot Trial of Mobile Technology for Adolescent Suicidality N/A
Completed NCT01944293 - Ketamine for Suicidality in Bipolar Depression Phase 1/Phase 2
Completed NCT02021344 - Mental Health First Aid for College Students N/A
Not yet recruiting NCT04686162 - Bae: A Smartphone Application for a Better Following Adolescents at Risk of Suicidal Behavior: Study of Acceptability and Preliminary Results of Efficacy N/A
Recruiting NCT05377177 - Cortical Inhibition as a Biomarker of Response in a Comparison of Bilateral Versus Unilateral Accelerated Theta Burst Stimulation for Suicidal Ideation in Treatment-Resistant Depression -COMBAT-SI N/A
Completed NCT05580757 - Pharmacists as Gate Keepers in Suicide Prevention: Needs of Pharmacists
Recruiting NCT05925322 - Brain Changes During Social Reward Psychotherapy for Mid- and Late-Life Suicidality N/A
Not yet recruiting NCT05427734 - Treating Drivers of Suicide Using Jaspr Health N/A
Recruiting NCT04112368 - Cyclical Neuroactive Steroid Changes, Arousal, and Proximal Suicide Risk: An Experimental Approach Phase 4
Completed NCT04026308 - Written vs Electronic Safety Planning Study N/A
Recruiting NCT05537376 - A Novel Peer-Delivered Recovery-Focused Suicide Prevention Intervention for Veterans With Serious Mental Illness N/A
Not yet recruiting NCT06311591 - Efficacy, Effectiveness, and Implementation of Jaspr Health in Emergency Department- Part B N/A
Recruiting NCT05894980 - How to Reduce Suicidal Thoughts and Impulsivity in Depression N/A
Not yet recruiting NCT05860257 - Transforming Adolescent Mental Health Through Accessible, Scalable, Technology-supported Small-group Instruction N/A